Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (1.609%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Share Repurchase Programme

5 Mar 2026 07:02

RNS Number : 4039V
Serco Group PLC
05 March 2026
 

LEI: 549300PT2CIHYN5GWJ21

5 March 2026

Serco Group plc

Share Repurchase Programme

 

Serco Group plc (the Company) today announces that, as outlined in the announcement of its 2026 Full Year Results on 5 March 2026, it intends to repurchase shares with a value of up to £75 million (the Programme).

 

This will occur during the period starting on 9 March 2026 and ending no later than 31 July 2026 (the Engagement Period). The aggregate number of shares acquired by the Company shall not exceed the balance of 81,273,394 shares remaining of the 102,385,524 shares authorised by shareholders at the 2025 Annual General Meeting. It is intended that any shares repurchased under the Programme will be transferred into treasury and subsequently cancelled.

 

The Company has entered into an agreement with RBC Europe Limited (RBC) under which RBC will manage the Programme for the Engagement Period. RBC will carry out the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. RBC will make trading decisions in relation to the Programme independently of the Company. During any closed periods, the Company will have no power to invoke any changes to the Programme, and it will be executed at the sole discretion of RBC. This arrangement is in accordance with Chapter 9 of the Financial Conduct Authority's Listing Rules and the Company's general authority to repurchase shares.

 

The Programme will also be conducted in accordance with the parameters of the safe harbour provisions set out in: (i) Article 5(1) of Regulation (EU) 596/2014 (including the delegated and implementing acts adopted under it); and (ii) the provisions of Commission Delegated Regulation (EU) 2016/1052 with regard to regulatory technical standards for the conditions applicable to buyback programmes and stabilisation measures (in each case as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as implemented, retained, amended, extended, re-enacted or otherwise given effect. There is no guarantee that the Programme will be implemented in full.

 

The Company intends to announce any purchase of Ordinary Shares under the Programme in line with the Financial Conduct Authority's Listing Rule 9.6.6, by no later than the end of the 7th daily market session following the date of execution of such purchase.

 

Ends

 

For further information please contact:

 

Jamie Hastings, Head of Investor Relations | +44 (0) 7718 195 074 | jamie.hastings@serco.com

Scot Marchbank, External Communications and Director | +44 (0) 7958 675 706 | scot.marchbank@serco.com

 

 

About Serco

Serco brings together the right people, the right technology, and the right partners to create innovative solutions that make a positive impact and address some of the most urgent and complex challenges facing the modern world.

 

With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility, and customer services.

 

Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management.

 

Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery.

 

More information can be found at www.serco.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSAORNBUORUR
Date   Source Headline
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20243:47 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20246:03 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 202410:00 amRNSPublication of the 2023 ARA and 2024 Notice of AGM
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSShare Repurchase Programme
4th Mar 20247:00 amRNSSerco completes acquisition of European Homecare
1st Mar 20245:43 pmRNSAnnual Financial Report
29th Feb 20247:00 amRNS2023 Final Results
2nd Feb 20244:33 pmRNSHolding(s) in Company
29th Jan 20244:46 pmRNSHolding(s) in Company
22nd Jan 202411:36 amRNSHolding(s) in Company
29th Dec 202310:00 amRNSTotal Voting Rights
27th Dec 20232:30 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSAcquisition of leading German immigration business
14th Dec 20237:00 amRNSPre-close trading update
11th Dec 202310:31 amRNSCancellation of Treasury Shares
6th Dec 20231:03 pmRNSDirector Declaration
5th Dec 202312:40 pmRNSHolding(s) in Company
27th Nov 20235:45 pmRNSBlock Listing Application
8th Nov 20237:00 amRNSSerco wins £200m electronic monitoring contract
25th Oct 20237:00 amRNSSerco appoints new CEO in Asia Pacific
20th Oct 20232:02 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSSerco wins new £350m contract
10th Oct 202312:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.